undefined

Add a bookmark to get started

Global Site
Africa
MoroccoEnglish
South AfricaEnglish
Asia Pacific
AustraliaEnglish
Hong Kong SAR ChinaEnglish简体中文
KoreaEnglish
New ZealandEnglish
SingaporeEnglish
ThailandEnglish
Europe
BelgiumEnglish
Czech RepublicEnglish
HungaryEnglish
IrelandEnglish
LuxembourgEnglish
NetherlandsEnglish
PolandEnglish
PortugalEnglish
RomaniaEnglish
Slovak RepublicEnglish
United KingdomEnglish
Middle East
BahrainEnglish
QatarEnglish
North America
Puerto RicoEnglish
United StatesEnglish
OtherForMigration
21 June 20231 minute read

CMS issues first HCPCS code and Medicare DME benefit category determination for therapeutic Virtual Reality Device

In this article for The Journal of Federal Agency Action, healthcare lawyers Kristi Kung, Rachel Ludwig, Deborah Samenow and Christine Lentz discuss why a recent determination by the Centers for Medicare & Medicaid Services amounts to a significant first step in pursuing Medicare coverage and reimbursement for virtual reality therapies.